During the recent session, TransCode Therapeutics Inc (NASDAQ:RNAZ)’s traded shares were 0.61 million, with the beta value of the company hitting 1.56. At the last check today, the stock’s price was $0.35, reflecting an intraday loss of -2.94% or -$0.01. The 52-week high for the RNAZ share is $66.33, that puts it down -18851.43 from that peak though still a striking 2.86% gain since the share price plummeted to a 52-week low of $0.34. The company’s market capitalization is $8.08M, and the average intraday trading volume over the past 10 days was 2.07 million shares, and the average trade volume was 7.44 million shares over the past three months.

TransCode Therapeutics Inc (NASDAQ:RNAZ) trade information

TransCode Therapeutics Inc (RNAZ) registered a -2.94% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.94% in intraday trading to $0.35, hitting a weekly high. The stock’s 5-day price performance is -13.17%, and it has moved by -54.46% in 30 days. Based on these gigs, the overall price performance for the year is -97.92%. The short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) is 2.55 million shares and it means that shorts have 0.17 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 48.04%. While earnings are projected to return 96.54% in 2025, the next five years will return 82.79% per annum.

RNAZ Dividends

TransCode Therapeutics Inc is due to release its next quarterly earnings on 2025-Apr-14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

TransCode Therapeutics Inc (NASDAQ:RNAZ)’s Major holders

TransCode Therapeutics Inc insiders own 0.15% of total outstanding shares while institutional holders control 0.67%, with the float percentage being 0.67%.

Also, the Mutual Funds coming in first place with the largest holdings of TransCode Therapeutics Inc (RNAZ) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund . Data provided on Feb 28, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 2.81 shares. This amounts to just over 0.01 percent of the company’s overall shares, with a $929.0 market value. The same data shows that the other fund manager holds slightly less at 1.18, or about 0.01% of the stock, which is worth about $389.0.